RT Journal Article SR Electronic T1 Doubling down on tumor suppressor deletion JF Science Translational Medicine FD American Association for the Advancement of Science SP eaba2903 DO 10.1126/scitranslmed.aba2903 VO 12 IS 524 A1 Sowalsky, Adam G. YR 2020 UL http://stm.sciencemag.org/content/12/524/eaba2903.abstract AB Codeletion of BRCA2 and RB1 increases prostate cancer sensitivity to PARP inhibitor therapy.